Complications

 
REMOVAL

REducing with MetfOrmin Vascular Adverse Lesions in type 1 diabetes

 
 
Genes determining risk of overt diabetic nephropathy (DN) and time to onset of ESRD in T1D patients with proteinuria

Project collects largest ever cohort for genetic study of Diabetes nephropathy in type 1 diabetes

 
Billede kommer
 
PERL - A multicenter clinical trial of allopurinol to prevent GFR loss in type 1 diabetes

PERL - A multicenter clinical trial of allopurinol to prevent GFR loss in type 1 diabetes

 
Identifying novel mechanisms that protect some people from diabetic complications

The PROLONG study: PROtective genetic and non-genetic factors in diabetic complications and LONGevity

 
 
 
PRIORITY

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria.

 
The role of reactive metabolites in diabetic complications

Can methylglyoxal predict the onset of diabetes complications?

 
The Steno T1 Risk Engine

Developing a screening method for cardiovascular disease in people with type 1 diabetes

Sidst opdateret 24-07-2015